Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New heart graft tested in humans for the first time

NCT ID NCT04545112

ENROLLING_BY_INVITATION Disease control Sponsor: Xeltis Source: ClinicalTrials.gov ↗

First seen Oct 31, 2025 · Last updated May 23, 2026 · Updated 28 times

Summary

This study tests a new type of bypass graft for people with severe blockages in multiple heart arteries. About 20 people will receive the graft during planned heart surgery. The goal is to see if the graft works safely and stays open for at least 30 days.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTI VESSEL CORONARY ARTERY DISEASE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • John Paul II Hospital Krakow

    Krąków, Poland

  • Medicover Hospital

    Warsaw, Poland

  • UZ Leuven

    Leuven, Belgium

  • Vilnius University Hospital Santaros Klinikos

    Vilnius, Lithuania

Conditions

Explore the condition pages connected to this study.